Follow

Submissions from 2021

Cardiovascular care in unusual places—delivering value beyond bricks and mortar, Tyler J Gluckman

Cardiovascular involvement in COVID-19: The good, the bad, and the unknown, Tyler J Gluckman

Peer-to-peer quality programs that actually work, Tyler J Gluckman

What did we learn from COVID-19?, Tyler J Gluckman

Submissions from 2020

Dangerous Liaisons in Pulmonary Hypertension, Sophia Airhart

Dangerous liaisons in pulmonary hypertension, Sophia Airhart

Link

ACCEL Lite: Case Rates, Treatment, and Outcomes in AMI During the COVID-19 Pandemic, Alison Bailey, Joseph Edward Marine, Tyler J Gluckman, and Yuvraj Chowdhury

Link

Analysis of changes in decision-making process during optical coherence tomography-guided percutaneous coronary interventions: insights from the LightLab initiative, Hiram Bezerra, Luis Dallan, Gabriel Tensol, Jana Buccola, Jason R Wollmuth, John Lopez, Richard Rapoza, Nick West, Brian Bergmark, and Kevin Croce

Link

COVID-19 and the CV service line: practical approaches for an unprecedented pandemic—Part 1, Jerry Blackwell, Cathie Biga, Geoffrey Rose, Tyler J Gluckman, John Rebok, and Eugene Yang

Link

Digital service in a virtual era: connecting the dots to help your community and save the world without leaving your home, Andrew Burgie, Liam Elkind, Alison Grady, and Xiaoyan Huang

Building and implementing team-based care in a successful financial model, Tyler J Gluckman

Cardiovascular issues related to COVID-19, Tyler J Gluckman

Coming to grips with chronic heart failure - keeping up with best practices, Tyler J Gluckman

Link

COVID-19’s Impact on Non-Communicable Diseases – The Enormous Toll it Has Taken, Tyler J Gluckman

Link

COVID-19 Web Series Part 10: Cardiovascular Issues Related to COVID-19, Tyler J Gluckman

Cross-industry real-world evidence (RWE), Tyler J Gluckman

First do no harm—approaches to PPE and testing, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Late-breaking clinical trials III, Tyler J Gluckman

Leveraging technology for quality improvement—what would Alexa and Siri say?, Tyler J Gluckman

Link

New Payment Model for E/M Services: Benefits and Risks of One Level of Service, Tyler J Gluckman

Non-communicable Diseases and the Toll it has Taken, Tyler J Gluckman

Quality of care, appropriate utilization criteria, the ACC-NCDR and professional code of ethics, Tyler J Gluckman

Link

Remote Patient Monitoring to Help with Cardiovascular Prevention During the COVID-19 Pandemic, Tyler J Gluckman

We have a service line: now what?, Tyler J Gluckman

We started. Now we need to implement (and get paid for) these subspecialty clinics, Tyler J Gluckman

Link

Managing Chronic Disease During COVID-19: Views From the US and Europe, Tyler J Gluckman, Katie Berlacher, and Simon G. Ray

Link

Race, Ethnicity, & Social Determinants in COVID-19: An Expert Panel Discussion, Tyler J Gluckman, Clyde W. Yancy, and Shrilla Banerjee

Practicing Cardiology in Portland 2020: Amidst Covid, Protests and Fire, Xiaoyan Huang

Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: A Propensity-Matched Analysis of Real World Data, Eric B Kirker

Adoption of a Strategy of Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement is Associated with Fewer Neurologic Events in a Large Volume Center, Ethan C Korngold

Intravascular Lithotripsy for Peripheral Artery Disease and Vascular Access, Ethan C Korngold

Strategies for Aorto-Iliac CTO Crossing, Ethan C Korngold

Transcarotid TAVR: The best alternative, Ethan C Korngold

Coronary Atherosclerosis & Cardiovascular Risk Factors in Subjects with Clonal Hematopoiesis, Michael Layoun

Advanced symposium peripheral arterial disease: controversies in treatment, Alejandro Perez

Hyperbaric medicine hyperbaric oxygen therapy: monoplace chamber, Alejandro Perez

Peripheral artery disease: basic principles for the wound care clinician, Alejandro Perez

Updates in Venous Disease Management, Alejandro Perez

Vascular testing, know why provider wants testing, Alejandro Perez

Embolization: thrombus, air, other, Jason R Wollmuth

Faculty panel - Intelligent intervention. Complex case examples incorporating lessons from SYNTAX 2, Jason R Wollmuth

High risk PCI program implementation and protocol development, Jason R Wollmuth

Live case panelist, case 3 & 4, Jason R Wollmuth

Live case panelist, case 5 & 6, Jason R Wollmuth

Link

New Advances in Avoiding Complications - Single Site Access in Impella-Assisted CTO PCI, Jason R Wollmuth

Retrograde CTO PCI, Jason R Wollmuth

Revascularization, support, and unloading: past, present, and future directions – protect IV: the synergy of MCS and complete revascularization, Jason R Wollmuth

Side branch access, Jason R Wollmuth

Single access Impella, Jason R Wollmuth

Link

Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth

Treating LV dysfunction – impact of complete revascularization on improvement in EF and heart failure, Jason R Wollmuth

Understanding how the use of routine oct workflow changes physician decisions: LightLab insights, Jason R Wollmuth

Link

COVID-19 lessons learned from China: disease management, clinical research and health policy, Wenhong Zhang, Sten H. Vermund, Xiaoyan Huang, and Kevin Ye

Submissions from 2019

High Tech, Meet High Touch, James G Beckerman

50 Years of Heart Valve Replacement: Effect of Prosthesis Choice on Long-Term Outcomes, Anthony P Furnary

Pharmacologic therapies to improve HF outcomes, Jill M Gelow

A case study on many views on value: Aortic valve replacement, Tyler J Gluckman

Advances in Heart Failure Management: How Will Recent Guideline Change Impact Your Treatment Selections, Tyler J Gluckman

Advances in heart failure management: How will recent guideline changes impact your treatment selections?, Tyler J Gluckman

Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - Executive Summary What Has Changed?, Tyler J Gluckman

Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice - We Should Have Left it Alone: JNC7 Was Just Fine, Tyler J Gluckman

Closing the stroke prevention gap in nonvalvular atrial fibrillation—Real world data and its impact on patient outcomes., Tyler J Gluckman

How Can ACCorg Help You Implement Cholesterol Guidelines in Your Practice, Tyler J Gluckman

How should my approach to high blood pressure change? Key takeaways from the guidelines and case-based blood pressure pearls, Tyler J Gluckman

How should my approach to hypertension change? Key Takeaways from the Guidelines and Case-based BP Pearls, Tyler J Gluckman

Interprofessional Heart Teams: What are They and Why do I Need Them?, Tyler J Gluckman

Intersection of Antiplatelets and Anticoagulants--What to do When a Patient Needs Both?, Tyler J Gluckman

Intersection of antiplatelets and anticoagulants—What to do when a patient needs both?, Tyler J Gluckman

Making the Most Out of ACCorg: Optimizing Your Experience with Your Digital Home, Tyler J Gluckman

Managing LDL-cholesterol with PCSK9 inhibitors: Identifying the patients, optimizing the outcomes, Tyler J Gluckman

Managing treatment gaps with PCSK9 inhibitors, Tyler J Gluckman

Meeting the triple (quadruple) aim: How do we collectively care for the patient? What does this mean for the health system?, Tyler J Gluckman

Overcoming Access Barriers and Practice Challenges to PCSK9 Inhibitor Implementation, Tyler J Gluckman

PCSK9 inhibitors: Addressing the unmet needs in hypercholesterolemia, Tyler J Gluckman

Pitfalls and challenges in the road to quality: Navigating and avoiding potholes, Tyler J Gluckman

Putting Your NCDR Registry to Work, Tyler J Gluckman

Redesigning quality of care and performance measures for primary and secondary prevention of ASCVD, Tyler J Gluckman

Strategies to Stomp Out Unwanted Clinical Care Variation: A Case-Based Approach, Tyler J Gluckman

Tailoring LDL-C lowering therapy to patient cardiovascular risk: Identifying effective strategies for patients with diabetes, Tyler J Gluckman

Treating high-risk patients with non-statin therapy for LDL-C lowering: Optimizing clinical outcomes, Tyler J Gluckman

What Are These Squiggly Lines? Fast Basics to Interpret 12-Lead ECGs, Benjamin J Hartwig

CCO 20: What can you do to prepare for value-based care, Xiaoyan Huang

HF Forum: Heart Failure Management Beyond Hospitalization, Xiaoyan Huang

Medical Neighborhood 20: Why Should Specialists Care?, Xiaoyan Huang

Prevention Forum: Cardiovascular Disease Prevention: Policy, Guidelines and Strategy, Xiaoyan Huang

Standardized Training of Cardiovascular Specialists: Bridging the Gap: Case Discussion, Xiaoyan Huang

Alternative Access Approaches in TAVR, Eric B Kirker

Case-Based Access Challenges Panel Discussant, Eric B Kirker

Structural IV Panel Discussant, Eric B Kirker

Live Case: Transcarotid TAVR, Eric B Kirker and Ethan C Korngold

Considerations for Managing TAVR and Concomitant Coronary Artery Disease in 2020: Challenging Coronary Access Case, Ethan C Korngold

CTO Crossing 1: Case Examples of Wire Escalation, Ethan C Korngold

Embrace Left Distal Radial Access: It’s the New and Best Approach!, Ethan C Korngold

Large-Bore Access and Closure: Resolution, Ethan C Korngold

Live Cases #6 - Live Case Discussant, Ethan C Korngold

Now That I See It, I Know How To Treat It! Presentation and Hands-On Session 1, Ethan C Korngold

Now That I See It, I Know How To Treat It! Presentation and Hands-On Session 2, Ethan C Korngold

PCI in the OBL/ASC Setting: Is it Safe?, Ethan C Korngold